Similar articles for PMID: 28408531

Year	Number of Results
1977	1
2005	1
2007	1
2008	2
2009	2
2010	1
2011	1
2012	1
2013	1
2014	1
2015	1
2016	13
2017	31
2018	24
2019	28
2020	28
2021	15
2022	6
2023	4
2024	0

1

⁶⁸Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.

Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M. Fendler WP, et al. J Nucl Med. 2017 Oct;58(10):1617-1623. doi: 10.2967/jnumed.117.190827. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408531 Free article. Clinical Trial.

2

Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.

Demirci E, Akyel R, Caner B, Alan-Selçuk N, Güven-Meşe Ş, Ocak M, Kabasakal L. Demirci E, et al. Nucl Med Commun. 2020 Aug;41(8):759-767. doi: 10.1097/MNM.0000000000001219. Nucl Med Commun. 2020. PMID: 32453205

3

68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.

Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal RK, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K. Fendler WP, et al. J Nucl Med. 2017 Feb;58(2):307-311. doi: 10.2967/jnumed.116.179192. Epub 2016 Aug 18. J Nucl Med. 2017. PMID: 27539839 Free PMC article.

4

⁶⁸Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement.

Basha MAA, Hamed MAG, Hussein O, El-Diasty T, Abdelkhalek YI, Hussein YO, Alasamer AF, Mohamed HAE, Deen DSE, Tantawy EF, Metwally MI, Zaitoun MMA, Aly SA, Altohamy JI, Mohamed AEM, Afifi AHM, Harb O. Basha MAA, et al. Abdom Radiol (NY). 2019 Jul;44(7):2545-2556. doi: 10.1007/s00261-019-02006-2. Abdom Radiol (NY). 2019. PMID: 30963182

5

⁶⁸Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer.

Vinsensia M, Chyoke PL, Hadaschik B, Holland-Letz T, Moltz J, Kopka K, Rauscher I, Mier W, Schwaiger M, Haberkorn U, Mauer T, Kratochwil C, Eiber M, Giesel FL. Vinsensia M, et al. J Nucl Med. 2017 Dec;58(12):1949-1955. doi: 10.2967/jnumed.116.185033. Epub 2017 Jun 21. J Nucl Med. 2017. PMID: 28637799 Free PMC article.

6

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

7

Detection Efficacy of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria.

Einspieler I, Rauscher I, Düwel C, Krönke M, Rischpler C, Habl G, Dewes S, Ott A, Wester HJ, Schwaiger M, Maurer T, Eiber M. Einspieler I, et al. J Nucl Med. 2017 Jul;58(7):1081-1087. doi: 10.2967/jnumed.116.184457. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209912 Free article.

8

In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?

Kulkarni SC, Sundaram PS, Padma S. Kulkarni SC, et al. Nucl Med Commun. 2020 Feb;41(2):139-146. doi: 10.1097/MNM.0000000000001110. Nucl Med Commun. 2020. PMID: 31714366

9

Interobserver variability, detection rate, and lesion patterns of ⁶⁸Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy.

Miksch J, Bottke D, Krohn T, Thamm R, Bartkowiak D, Solbach C, Bolenz C, Beer M, Wiegel T, Beer AJ, Prasad V. Miksch J, et al. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2339-2347. doi: 10.1007/s00259-020-04718-w. Epub 2020 Mar 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 32157427 Free PMC article.

10

⁶⁸Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.

Schmidkonz C, Cordes M, Schmidt D, Bäuerle T, Goetz TI, Beck M, Prante O, Cavallaro A, Uder M, Wullich B, Goebell P, Kuwert T, Ritt P. Schmidkonz C, et al. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1862-1872. doi: 10.1007/s00259-018-4042-z. Epub 2018 May 3. Eur J Nucl Med Mol Imaging. 2018. PMID: 29725716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year